Single cell analysis of a thyroid cancer cell line resistant to lenvatinib

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Neoadjuvant lenvatinib in invasive differentiated thyroid cancer2024
2. 2Molecular profiling of advanced thyroid cancer: characterizing tumors for targeted treatment2024
3. 3TP53 mutations associate with poor response to lenvatinib treatment for advanced thyroid cancer2024
4. 4Liquid biopsy in the follow-up of a patient with braf positive anaplastic thyroid cancer and breast cancer2024
5. 5Impact of short lenvatinib interruptions in advanced thyroid cancer patients2024